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Introduction
Fragile X syndrome (FXS) is an inheritable form of mental retardation caused by expansion of CGG trinucleotide repeats within FMR1 gene on X chromosome. This condition results in FMR1 gene silencing and loss of fragile X mental retardation protein (FMRP) expression (Feng et al., 1995; O'Donnell and Warren, 2002) . FMRP is an RNA-binding protein that associates with polyribosomes and regulates translational efficiency and trafficking of certain mRNAs (Miyashiro et al., 2003) . FMRP is a typical selective mRNA-binding protein with several RNA-binding motifs (Siomi et al., 1994) . By binding to mRNAs and interacting with other proteins, FMRP participates in regulating gene expression at the post-transcriptional level including mRNA dendritic localization and translation (Darnell and Klann, 2013) . Approximately 4% of mouse brain mRNAs interact with FMRP, including transcription factors (Deacon et al., 2017) . FMRP also participates in primiRNA processing via controlling Drosha translation (Wan et al., 2017) . Fmr1 knockout (KO) mice display many deficits similar to FXS symptoms, including impaired social interaction, cognitive disability, hyperactivity, and enhanced auditory startle responses (Restivo et al., 2005; Brennan et al., 2006; Yang et al., 2015) .
Trace fear memory requires activity of medial prefrontal cortex (mPFC) and hippocampus and is sensitive to attention-distracting stimuli (Zhao et al., 2005) . Classical conditioning paradigms is typically used for delayed conditioning, in which conditioned stimulus is immediately followed by (or co-terminates with) unconditioned stimulus. By contrast, trace fear conditioning introduces unconditioned stimulus after specific time interval following conditioned stimulus (Han et al., 2003) . Trace fear conditioning paradigm requires attention. Long-term potentiation (LTP) is a type of long-lasting synaptic plasticity and is believed to be involved in learning and memory (Bliss and Collingridge, 1993) . Protein synthesis is considered an important component of late-phase LTP (L-LTP). FMRP is believed to regulate protein synthesis at synapses by providing a local source of newly synthesized proteins (Jin and Warren, 2003) . Thus, loss of FMRP is considered as the main cause for deficit of L-LTP in prefrontal cortex and impairment of trace fear memory in Fmr1 KO mice (Zhao et al., 2005) .
Progranulin (PGRN) is PC cell-derived growth factor coded by GRN gene with seven granulin repeats (Hrabal et al., 1996) . This precursor was originally isolated as autocrine growth factor from culture medium of mouse teratoma cell line PC. PGRN expression increases in activated microglia in several neurodegenerative diseases, including Creutzfeldt-Jakob disease, motor neuron diseases, and Alzheimer's disease (Baker et al., 2006) . PGRN is reported to promote neurite outgrowth and cell survival (Van Damme et al., 2008; Gao et al., 2010; Gass et al., 2012) . PGRN deficiency causes abnormal circuit-specific synaptic pruning by microglia via complement activation (Lui et al., 2016) . As synaptic pruning is impaired in FXS (Zoghbi and Bear, 2012; He and Portera-Cailliau, 2013) , we hypothesize that PGRN may play a role in pathology of FXS.
PGRN binds to tumour necrosis factor receptor 1 (TNFR1) and TNFR2 receptors and acts as an anti-inflammatory cytokine (Tang et al., 2011) . TNFa plays a critical role in mediating synaptic scaling and is essential in early cognitive development (Stellwagen and Malenka, 2006) . This factor is synthesized as a membrane-bound pro-protein comprising 233 amino acids; it is cleaved by specific protease, TNFa-converting enzyme, to generate mature soluble TNFa (Black et al., 1997) . TNFR1 can bind to either soluble TNFa or to transmembrane TNFa, with a preference for soluble TNFa. By contrast, TNFR2 is preferentially activated by transmembrane TNFa and protects neurons against excitotoxicity (Yang et al., 2002; Krishnan et al., 2009) . Compared with TNFa, PGRN shows significant higher affinity for TNFR2 (Tang et al., 2011) . Using a gene-chip screening technique, we noted a 1.58-fold increase in Grn mRNA in cortex of Fmr1 KO mice. However, functional roles of elevated PGRN in synaptic plasticity and cognitive performance in FXS are not clear.
In the present study, we observed higher protein levels of PGRN in Fmr1 KO mice than in wild-type mice. Partial knock-down of the GRN gene alleviated abnormal dendritic spine development, deficit of LTP, and learning and memory impairment in FXS model mice. The present study may provide a potential therapeutic target for the treatment of FXS.
Materials and methods Animals
Eight-week-old Fmr1 KO (FVB.129P2-FMR1tm1Cgr/J; stock #4624) and control wild-type (FVB.129P2-Pde6b + Tyrc-ch/ AntJ; stock #4828) mice were obtained from The Jackson Laboratory. All animals were fed in groups of three per cage under standard laboratory conditions (12 h light/12 h dark, temperature at 22-26 C, air humidity 55-60%) with water and mice chow ad libitum. Experimental procedures were approved by the Institutional Animal Care and Use Committee of The Fourth Military Medical University.
Recombinant PGRN
Recombinant mouse PGRN-His tag with a purity of over 90% purity (determined by SDS-PAGE) was purchased from Sino Biological Inc (cat NO. 50396-H08H). The secreted recombinant mouse PGRN comprises 583 amino acids and has a predicted molecular weight of 63 kDa. As a result of glycosylation, the apparent molecular weight of recombinant PGRN is $70-90 kDa in SDS-PAGE under reducing conditions (Kanazawa et al., 2015) . As PGRN induces phosphorylation of extracellular signal-regulated kinase (ERK) and RAC-alpha serine/threonine-protein kinase (AKT) (Chen et al., 2013; Wang et al., 2017) , the activity of recombinant PGRN was determined by testing the changes of phosphorylated ERK and AKT in cultured neurons.
RNA sequencing
The TruSeq RNA sample prep kit (Illumina) and 1 mg of total RNA were used to make poly-A selected and barcoded RNASeq libraries for each mPFC sample. Adapters containing seven nucleotide indexes were ligated to the double-stranded cDNA. The DNA was purified from enzymatic reactions and the size selection of the library was performed with AMPure Õ XP beads (Beckman Coulter Genomics). Libraries were assessed for concentration and fragment size using the DNA High Sensitivity Assay on the LabChip Õ GX (Perkin Elmer) and using the qPCR KAPA Library Quantification Kit (Kapa Biosystems). The libraries were pooled and sequenced on a 100 base pairs (bp) paired-end illuminaHiSeq 2500 run (Illumina). The sequenced reads were aligned to the reference sequence (Ensembl) using TopHat version 1.4.1. The alignments allowed up to 2 bp mismatches per 25 bp segment, and reads were removed that aligned to more than 20 different genomic regions. Transcript abundances and splice variant identification was done using Cufflinks version 1.3 using the BAM alignment files obtained from TopHat. BigWig coverage files were generated from the BAM alignment files using the UCSC genome browser tools. The identified lists of genes were subjected to functional annotation, clustering Visualization and Integrated Discovery (DAVID) Bioinformatics Database (https://david.ncifcrf.gov/).
Immunofluorescence staining
Mice were deeply anaesthetized by intraperitoneal (i.p.) injection of sodium pentobarbital (0.14 g/kg). This was followed by perfusion with 0.9% NaCl and then 4% paraformaldehyde (PFA) in 0.1 mM phosphate-buffered saline (PBS) through aorta. Brains were removed and post-fixed in 4% PFA overnight at 4 C. Free-floating coronal sections (20 mm) were obtained using a freezing microtome (CM1950, Leica). Prefrontal cortex sections containing the mPFC were washed in 0.1 mM PBS buffer, permeabilized with 0.3% Triton TM in 5% normal goat serum for 1 h. Then the sections were incubated in primary antibodies (anti-PGRN, 10 mg/ml; anti-b-tubullin III, 1:500) overnight at 4 C in 10% normal goat serum. After washing, sections were incubated with secondary Cy3-conjugated anti-sheep antibody (1:200, CWBIOTECH), Alexa Fluor Õ 488-conjugated anti-mouse antibody (1:200, CWBIOTECH) for 2 h at room temperature. Diluted Hoechst 33342 in 0.1 mM PBS (1:1000) was applied to sections after washing for 5 min to stain nuclei. Sections were mounted onto slides using 50% glycerinum. The slides were observed using a confocal laser microscope (FV1000, Olympus), and images were captured by Fluoview 1000 (Olympus) using standard laser lines and filters.
Western blot analysis
Western blot analysis was performed as described previously (Yang et al., 2015) . PDVF membranes (Millipore) were probed with anti-p-ERK1/2 (1:200, Santa Cruz Biotechnology), anti-ERK1/2 (1:1000, Santa Cruz Biotechnology), anti-PGRN (0.5 mg/ml, R&D Systems), anti-FMRP (1:1000, Santa Cruz Biotechnology), anti-AKT(1:1000, Cell Signaling Technology), anti-p-AKT (1:1000, Cell Signaling Technology), anti-mTor (1:1000, Cell Signaling Technology), anti-p-mTor (1:1000, Cell Signaling Technology), anti-b-catenin (1:1000, Cell Signaling Technology), anti-p-b-catenin (1:1000, Cell Signaling Technology), anti-TNFR1 (1:200, Santa Cruz Biotechnology), anti-TNFR2 (1:200, Santa Cruz Biotechnology), anti-RELA (1:1000, Bioworld Technology), anti-RELB (1:1000, Bioworld Technology), anti-p50 (1:1000, Cell Signaling Technology), anti-p52 (1:1000, Abcam), anti-JNK (1:1000, Cell Signaling Technology), anti-p-JNK (1:1000, Cell Signaling Technology) and anti-b-actin (1:10 000, Sigma). For data quantification, band intensity was expressed relative to the loading control (bactin). For quantifying target protein in conditioned medium, equal volume of sample was loaded. Band density was measured with a Tanon5200 imager, normalized to b-actin level and expressed as a percentage of control.
Enzyme-linked immunosorbent assay
ELISA was used to quantify PGRN levels in plasma and mPFC by ELISA kits (cat no. ab213473, Abcam) according to the manufacturer's instructions.
Primary neuronal culture
Cortical neurons were cultured from embryonic Day 15 of wild-type or Fmr1 KO mice as described previously (Yang et al., 2015) . Cultures were incubated at 37 C in 95% oxygen/5% carbon dioxide with 95% humidity, and used for western blot experiments at 14 days in vitro (DIV). To detect the effects of different PGRN concentrations on cultured neurons, PGRN (0, 10, 20, 50, 75 , 100, 200 ng/ml) was added in the culture medium throughout the culture process.
Phalloidin staining

PGRN was added into Neurobasal
Õ culture medium and sustained in whole neuron culture process. Cultures were fixed in 4% PFA for 20 min at room temperature after being cultured on a coverslip for 21 days when different types of spines could clearly be observed (Feng et al., 2000) . After being blocked for 30 min (5% bovine serum albumin and 0.1% Triton TM X-100), cells were stained with anti-b-tubullin III (1:1000) overnight at 4 C followed by secondary FITC-conjugated anti-mice antibody (1:200) and TRIC-Phalloidin (1 mg/ml) for 2 h at room temperature. Diluted Hoechst 33342 (1:1000, in 0.1 mM PBS) was applied to sections after washing for 5 min to stain nuclei. Cover slips were mounted onto slides using 50% glycerinum. Photography and analysis of immunoreactivity were performed in an investigator-blinded manner in three independent experiments. Each experiment used three or more coverslips to obtain the sample of isolated neurons for analysis. Detailed spine analysis is referred to the procedure used in Golgi staining.
Small interfering RNA transfection
Synthetic siRNAs against mouse PGRN and TNFR2 were labelled with Alexa Fluor Õ 488 as previously described (Nadif Kasri et al., 2011) . Oligonucleotides were synthesized by GenePharma. The PGRN-siRNAs were generated as in previous studies (Guo et al., 2010; Tapia et al., 2011; Lim et al., 2012) .
The Tnfrsf1b/TNFR2 target sequence was chosen for the best knocking down efficiency from three designed sequences:
For siRNA transfection, each siRNA aliquot (0, 15, 30, 60, 100, and 200 nmol/ml/well) was incubated in cell culture medium using DOTAP Liposomal Transfection Reagent (Roche) at in vitro 1 day according to the manufacturer's protocol.
Lentiviral constructs and stereotactic injection
0 ) and scrambled (5 0 -TTC TCCGAACGTGTCACGT-3 0 ) shRNAs were inserted into LV3 plasmid and packaged into lentivirus were by Genepharma. The double-stranded DNA fragments were inserted into the pSUPER vector according to the manufacturer's instructions using LV3 plasmid with green fluorescent protein (GFP) fusions. For stereotactic injection, mice were anaesthetized with gaseous isoflurane. Lentivirus (1 ml with 3 Â 10 5 infectious viral particles) were stereotaxically microinjected into bilateral mPFC area (AP, + 2.43 mm; ML, AE0.28 mm; DV, À1.81 mm, angled 14 toward the midline in the coronal plane) at a rate of 0.1 ml/min for 10 min per side. The hole was sealed with bone wax. Mice were used for further experiments 2 weeks after injection.
Locomotor activity test
Behavioural tests were carried out 2 weeks after lentivirus injection or 1 week after the drug treatment. Locomotor activity was conducted in the open field as described previously (Tian et al., 2013) . It was carried out in the open field, a square arena (30 cm Â 30 cm Â 30 cm) with clear Plexiglas Õ walls and floor, and placed inside an isolation chamber with dim illumination and a fan. Mice were placed in centre of the box and allowed to freely explore for a 15 min period. Mice were videotaped using a camera fixed above the floor and analysed with a video-tracking system.
Trace fear memory test
Trace fear conditioning was performed in an isolated shock chamber (Med Associates) (Yang et al., 2012) . The conditioned stimulus used was an 80 dB white noise, delivered for 15 s, and the unconditioned stimulus was a 0.7 mA scrambled foot shock for 0.5 s. Mice were acclimated for 60 s and were presented with 10 conditioned stimulus-trace-unconditioned stimulus intertrial interval (ITI) trials (trace, 30 s; ITI, 210 s). One day after training, mice were acclimated for 60 s followed by 10 conditioned stimulus-ITI trials (ITI, 210 s) in a novel chamber to test for trace fear memory. All data were video recorded using FreezeFrame video-based conditioned fear system and analysed by Actimetrics Software (Coulbourn Instruments). Average freezing for the baseline and for each ITI during training and testing sessions was analysed. Bouts of 1 s were used to define freezing.
Golgi staining and spine morphology analysis
Two weeks after virus injection, mice brain were removed and fixed in 2% PFA/2.5% glutaraldehyde for 424 h, then stained with the Rapid Golgi protocol as previously described (Lee et al., 2004) . Brains were sectioned (120 mm) using a vibratome. After gradient ethanol dehydration, slices were mounted onto slides using neutral balsam and imaged under Olympus BX51 light microscope using DP-BSW software with 100 Â/ NA 1.4 oil immersion lens. Basal dendrites were randomly selected for imaging. Dendritic spine density was calculated as number of spines per 10 mm dendritic length from the soma. Spine morphology was classified according to previously described criteria: 'thin' type has a long neck and a small head; 'stubby' type has a large head but does not have a neck; 'mushroom' type has a large head with a thick neck. Values from neurons derived from the same animal were consolidated together and averaged.
Co-immunoprecipitation
Medial PFC was rapidly removed and washed in ice-cold 0.1 mM PBS and lysed in buffer containing 50 mM Tris-HCl (pH 7.4), 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, and protease inhibitors. For immunoprecipitation, equal amounts of protein were incubated with antibodies for overnight at 4 C. Then, resuspended magnetic beads (Thermo Fisher) were added to each sample and incubated for 2 h at 4 C. Magnetic beads were washed three times with lysis buffer and resuspended in SDS sample buffer. Samples were separated on 8-12% SDS-PAGE gels, and specific proteins were measured by immunoblotting.
Multielectrode array recording
Mice were anaesthetized with gaseous isoflurane and decapitated. Whole brain was rapidly removed and immersed into a cold bath of oxygenated (equilibrated with 95% O 2 and 5% CO 2 ) artificial CSF containing (in mM): NaCl 124, KCl 2.5, NaH 2 PO 4 1.0, MgSO 4 1, CaCl 2 2, NaHCO 3 25 and glucose 10, pH 7.35-7.45. After cooling for 1-2 min, appropriate portions of brain were then trimmed and the remaining brain block was glued onto the ice-cold stage of a vibrating tissue slicer (Leica, VT1000S). Field excitatory postsynaptic potentials (fEPSPs) were recorded with a commercial 64-channel recording system (MED64; Panasonic Alpha-Med Sciences) as previously reported (Yang et al., 2015) . Briefly, slices were placed on a MED64 probe (MED-P515A, 8 Â 8 array; interpolar distance 150 mm) covering most of the 64 electrodes. Electrical stimulation was delivered to one channel located within deep layer V of the mPFC, and evoked fEPSPs were monitored and recorded from the other 63 channels. Field EPSPs evoked at both superficial layer (Fig. 2C , layer II-III) and deep layer of mPFC were amplified by a 64-channel amplifier. Only the data from activated channels around the stimulus channel were used for fEPSPs analysis. Baseline responses were evoked at 0.017 Hz for at least 30 min before LTP induction by a typical theta burst-stimulation protocol consisting of five bursts, each containing four pulses at 100 Hz, with an interburst interval of 200 ms.
Whole-cell patch-clamp recording
Medial PFC slices were gathered as mentioned above. After 1 h of recovery, slices were placed in a recording chamber on the stage of an Olympus microscope with infrared digital interference contrast optics for visualization of whole-cell patch-clamp recordings. EPSCs were recorded from layers II-III pyramidal cells in the mPFC with an Axon 200B amplifier (Axon Instruments). Electrical stimuli (0.2 ms duration) were delivered by a bipolar tungsten stimulating electrode placed in layer V of the mPFC. For mEPSC and input-output recordings, recording pipettes (3-5 M) were filled with solution containing 145 mM K-gluconate, 5 mM NaCl, 1 mM MgCl 2 , 0.2 mM EGTA, 10 mM HEPES, 2 mM Mg-ATP, and 0.1 mM Na 3 -GTP, adjusted to pH 7.2 with KOH (280-300 mOsm). Neurons were clamped at À70 mV. Access resistance (15-30 M) was monitored throughout the experiment. Data were discarded if access resistance changed 415% during an experiment.
Chemical long-term potentiation induction
Cultured cortical neurons were used on in vitro Day 14. Neurons were stimulated by 60 mM KCl or 200 mM glycine for 10 min to induce a chemical LTP. Then KCl or glycine was removed and replaced by fresh culture medium. Neurons were collected in ice-cold RIPA lysis for further analysis 3 h later.
Chromatin-immunoprecipitation analysis
Chromatin-immunoprecipitation (ChIP) was performed as described previously (Konig et al., 2017) . Briefly, mPFC tissues were fixed in 1% formaldehyde, left at 37 C for 10 min and quenched with 2 mM glycine. After washes, tissues were lysed in sonication buffer (1% Triton TM X-100, 0.1% Na-deoxycholate, 50 mM Tris-Cl, pH 8.10, 150 mM NaCl, 5 mM EDTA, 0.1% PMSF, 1% SDS and protease inhibitor cocktail) for 3 Â 10 s on ice (Scientz Biotechnology). The lysates were spun at 13 000rpm for 2 min. Supernatants underwent agarose gel electrophoresis for fragment length check (100-400 bp) and were used for immunoprecipitation. ChIP grade protein G magnetic beads (Cell Signaling Technology), foetal bovine serum and fish sperm DNA (Sigma) were added and incubated for 30 min for preclearing, with 5 ml of rabbit monoclonal anti-RELB (cat no. 10544, Cell Signaling Technology) for immunoprecipitation overnight at 4 C. Samples were spun and underwent a series of washing steps before extraction of DNA using 1% SDS, 0.1% NaHCO 3 . Samples were incubated at 65 C for 2-4 h and purified using a PCR purification kit. The ChIP production was quantified by Qubit 2.0 (Invitrogen) and analysed by electrophoresis.
Statistical analysis
Data were expressed as mean AE SEM (standard error of the mean). Statistical comparisons were performed by either unpaired Student's t-test, one-way, and two-way ANOVA. If ANOVA was significant, post hoc comparisons were followed by Bonferroni's test. Repeated measurement data was analysed by univariate ANOVA after lower-bound correction. In all cases, P 5 0.05 was considered statistically significant.
Results
Level of PRGN increases in the brain of Fmr1 knockout mice
High-throughput RNA sequencing indicated GRN mRNA was upregulated in the mPFC KO mice (Fig. 1A, B and Supplementary Fig. 1 ). Higher PGRN expression was found in mPFC and anterior cingulate cortex of Fmr1 KO mice compared with wild-type mice (P = 0.008 in ELISA detection, Fig. 1C and D; P 5 0.001 in western blot detection, unpaired Student's t-test, Fig. 1E ), but not in hippocampus (P = 0.61 in ELISA detection; P = 0.47 in western blot detection, unpaired Student's t-test), indicating differential regulation of central PGRN levels in neurodegeneration (Wilke et al., 2017) . As PGRN is a putative ligand of the TNFa receptor (Tang et al., 2011) , we also measured TNFa concentration but did not observe a difference between wild-type and KO mice (P = 0.42, unpaired Student's t-test, Supplementary Fig. 2A and B ). In addition, PGRN level showed developmental changes in mice brain. The level of PGRN in mPFC increased from postnatal Day 3, peaked on postnatal Day 14, and then gradually decreased at postnatal Day 56, and were higher in Fmr1 KO mice than in wild-type mice (Fig. 1F) . Cultured cortical neurons also exhibited the same developmental changes in PGRN expression (Fig. 1G ). In cultured neurons or microglia test, PGRN levels in cell lysate and culture medium were higher from Fmr1 KO mice than that from wildtype mice (Supplementary Fig. 2E ). Combining with the fact that Grn mRNA was increased in KO mice, it implies that excessive PGRN is due to an increase in the production. Changes in PGRN suggest that PGRN may play a critical role in early postnatal brain development.
High level of PGRN impairs spine maturation and synaptic transmission
To detect effects of excessive PGRN on neuron morphology, we added recombinant mouse PGRN or normal mouse IgG to cultured neurons and analysed density and morphology of dendritic spines by phalloidin staining (Fig.  2A) . Exogenous PGRN (100 ng/ml) increased density of spines [F(3,36) = 15.31, P 5 0.001], but decreased number of mature spines (mushroom and stubby morphologies) in wild-type neurons [F(3,36) = 17.42, P 5 0.001], inducing a similar phenotype as cultured Fmr1 KO neurons (Fig. 2B) . As PGRN is a well-known neurotrophic factor and higher level in the brain was believed to be part of a neuroprotective mechanism, these results seemed puzzling (Kanazawa et al., 2015; Ma et al., 2017) . To investigate the function of PGRN further, different PGRN concentrations were tested in the cultured neurons. Low PGRN levels (10-50 ng/ml) increased the density and ration of mature dendritic spines in wild-type neurons but not in KO neurons, while high PGRN levels (75-200 ng/ml) significantly decreased the ratio of mature dendritic spines in the wild-type neurons (Fig. 2C) . Consistent with this, slight downregulation of PGRN by low levels of siRNA-1 increased the ratio of mature dendritic spines in KO neurons; however, higher Scale bar = 500 mm. Bottom: Perfusion of PGRN (100 ng/ml) enhanced basal synaptic transmission in wild-type but not in KO mPFC slices. n = 8 slices/five wild-type mice, n = 7 slices/four KO mice. Unpaired Student's t-test; **P 5 0.01 versus wild-type slices. (F) Top: Sample traces show input-output (I-O) relationships of AMPA receptor-mediated EPSCs before and after PGRN treatment in wild-type and KO mice. Bottom: Plots of input-output curves show PGRN increased synaptic transmission in wild-type mice (n = 9 slices/five mice) but not in KO mice (n = 13 slices/seven mice). Unpaired Student's t-test; *P 5 0.05, **P 5 0.01 versus PGRN treated KO mice. WT = wild-type. levels of PGRN siRNA-1 decreased the ratio of mature dendritic spines in both wild-type and KO neurons (Fig.  2D) . These results indicated a dual-directional effect of PGRN on dendritic spine maturation, i.e. a low level of PGRN is essential for the spine development; but a high level of PGRN retards the spine maturation. Next, synaptic transmission in mPFC was recorded using a MED64 system (Fig. 2E ). Acute exogenous PGRN (100 ng/ml, 1 h) perfusion enhanced basal synaptic transmission in wild-type mPFC slices, but not in KO slices (P = 0.001, unpaired Student's t-test, Fig. 2E ). Input-output recording was used to examine the synaptic facilitation of PGRN further. Evoked EPSC amplitude was increased after exogenous PGRN (100 ng/ml) perfusion in wild-type mice but not in KO mice [stimulation intensity at 35 V: F(3,40) = 26.41, P 5 0.001, Fig. 2F ], indicating altered responses to PGRN between wild-type and KO mice. These results indicate that excessive PGRN may impair dendritic spine development and synaptic facilitation in Fmr1 KO mice.
RNA interference of PGRN restores late-phase long-term potentiation in the medial prefrontal cortex Based on findings showing that excessive PGRN impaired synaptic transmission, we aimed to discover whether knock-down of Grn could rescue LTP deficit in KO mice. Local microinjection of lentivirus short-hairpin RNA (shRNA, co-expressed with GFP, Fig. 3A) , which targets GRN in mPFC, significantly reduced PGRN protein levels 1 week after microinjection in both wild-type and Fmr1 KO mice [F(3,16) = 17.45, P 5 0.001, Fig. 3B ]. Deficit of LTP was reported in mPFC and hippocampus of FXS (Huber et al., 2002; Zhao et al., 2005; Lauterborn et al., 2007) . MED64 system recordings indicated that partial knock-down of PGRN did not affect maintenance of L-LTP in wild-type mice (P = 0.17, unpaired Student's t-test, Fig. 3C ). However, knock-down of PGRN restored L-LTP in Fmr1 KO slices (P 5 0.001, unpaired Student's t-test, Fig. 3D ). This result confirms our hypothesis that excessive PGRN disrupts synaptic plasticity in KO mice.
Regulation of dendritic development by PGRN
Fmr1 KO mice exhibit increased spine density and immature filopodia-like spine (Michalon et al., 2012) . Using Golgi-Cox staining, we measured spine density and morphology in mPFC neurons (Fig. 4A) . Spines are typically categorized into filopodia, thin, stubby, and mushroom types, according to their sizes and shapes (Harris et al., 1992) . Mushroom spines (large spines with big head and thick neck) are thought to be stable, contain the highest number of AMPA receptors, and are suggested to act as 'memory spines'. Total spine density increased in KO mice [F(3,76) = 5.85, P = 0.018, Fig. 4B ]. However, proportion of mushroom spines in KO mice was lower than that in wild-type mice, and was reversed by PGRN shRNA injection [F(3,76) = 27.68, P 5 0.001, Fig. 4C ]. The increased spine density in KO mice was also reversed by PGRN shRNA injection [segment 91-100 mm, F(3,76) = 12.47, P 5 0.001, Fig. 4D ]. Dendritic spines are functional units of synaptic transmission; mature morphology of spines reflects functional recovery of PGRN shRNA-treated mice. 
Knock-down of PGRN restores behavioural performance of Fmr1 KO mice
Metabotropic glutamate receptor 5 (mGluR5) and glycogen synthase kinase 3 beta (GSK-3b) signalling pathways are exaggerated in FXS (Bear et al., 2004; Levenga et al., 2010) . Mammalian target of rapamycin (mTOR) and ERK pathways are proposed to couple mGluRs to form translational machinery (Gebauer and Hentze, 2004) . Microinjection of PGRN shRNA restored upregulation of phosphorylated AKT, mTOR, ERK, and b-catenin to basal levels in mPFC of KO mice (Supplementary Fig. 3 ). Hyperactivity is frequently observed in FXS patients, a symptom that was reproduced in Fmr1 KO mice. This increase in locomotor activity returned to control level 1 week after microinjection of PGRN shRNA into mPFC [F(3,20) = 15.84, P 5 0.001, Fig. 5A ]. Trace fear conditioned learning requires intact mPFC function. This paradigm differs from the classic delay paradigm in that animals must sustain attention during trace interval to learn conditioned stimulus-unconditioned stimulus association. Conditioned stimulus, an 80 dB white noise delivered for 15 s, was delivered 30 s before (trace) unconditioned stimulus, a 0.7 mA scrambled foot shock. Mice were presented with 10 conditioned stimulus-trace-unconditioned stimulus trials with an ITI of 210 s. One day after training, mice received 10 conditioned stimulus-ITI trials in a novel chamber to test for trace fear memory (Fig. 5B) . Both wildtype and KO mice successfully responded to trace-fear conditioning after 10 conditioned stimulus-unconditioned stimulus pairings and showed increased freezing throughout training [ITI 10, F(3, 20) = 23.17, P 5 0.001, Fig. 5C ]. Lower learning ability was found in KO mice but was restored with PGRN shRNA microinjection. On testing day, average freezing time was significantly increased in KO mice with mPFC Fig. 5D ]. These results indicate that partial downregulation of PGRN could relieve trace fear memory impairment in KO mice. However, PGRN shRNA injection did not improve the performance of KO mice in elected plus maze, rotarod test, and forced swimming test ( Supplementary Fig. 4) . Possibly, injection of mPFC was insufficient to ameliorate abnormal behaviours controlled by other brain regions.
Excessive PGRN impairs long-term potentiation through the TNFR2-dependent pathway PGRN can directly bind to TNFRs. However, the subtype of TNFRs involved in PGRN-dependent regulation of learning and memory is not known. Co-immunoprecipitation revealed that PGRN bound mainly to TNFR2 [F(3,16) = 31.71, P 5 0.001], whereas TNFa bound to either TNFR1 or TNFR2 in wild-type and KO mPFC lysates (Fig.  6A) . Next, roles of TNFR1 and TNFR2 in synaptic plasticity were explored. Glycine (200 mM) application effectively induced chemical LTP and p-CREB translocation into nucleus in cultured neurons [F(5,24) = 28.87, P 5 0.001, Fig.  6B ]. This translocation was attenuated by perfusion of TNFR2 blocking antibody (100 ng/ml) (cat no. 113302, BioLegend) but not by TNFR1 blocking antibody (cat no. 113102, BioLegend). Similarly, KCl (60 mM)-induced elevation of p-CREB was blocked by TNFR2 antibody perfusion but not by TNFR1 antibody perfusion in cultured neurons [F(3,16) = 34.72, P 5 0.001, Fig. 6C ]. Furthermore, in mPFC slices, theta burst-stimulation-induced L-LTP was blocked by Nuclear protein PARP was used as a loading control. n = 5 dishes in each group. Two-way ANOVA followed by Bonferroni's post hoc test; *P 5 0.05, **P 5 0.01 between the groups as shown. (C) In cultured neurons, TNFR2 but not TNFR1 antibody suppressed KCl-induced elevation of p-CREB. n = 5 dishes in each group. Two-way ANOVA followed by Bonferroni's post hoc test; **P 5 0.01 between the groups as shown. (D) Left: Accumulative fEPSPs recordings at mPFC from wild-type animals. Right: Averaged fEPSPs slope during the last 1 h. Arrow indicates the point of theta burst-stimulation application. TNFR2 antibody (100 ng/ml) inhibited the L-LTP in mPFC slices. n = 8 slices/four mice in each group. One-way ANOVA followed by Bonferroni's post hoc test; **P 5 0.01 between the groups as shown. (E) Left: Accumulative fEPSP recordings at mPFC from wild-type animals. Right: Averaged fEPSP slope during the last 5 min. Arrow indicates the point of PGRN (100 ng/ml) application. n = 8 slices/four mice in each group. One-way ANOVA followed by Bonferroni's post hoc test; **P 5 0.01 between the groups as shown. (F) Western blot samples showing the protein levels in culture wild-type neurons. (G) TNFR2 antibody blocked the phosphorylation of GluA1 (p-GluA1-ser845/831) induced by PGRN (100 ng/ml) or glycine (200 mM) in wild-type cultured neurons. n = 5 dishes in each group. One-way ANOVA followed by Bonferroni's post hoc test; **P 5 0.01 between the groups as shown. WT = wild-type.
perfusion of TNFR2 antibody but not TNFR1 antibody [F(2,21) = 17.57, P 5 0.001, Fig. 6D ]. These results indicate that activation of TNFR2, but not TNFR1, is necessary for L-LTP expression. To explore the connection between PGRN and TNFRs, TNFR2 or TNFR1 antibodies were added to artificial CSF 1 h before PGRN treatment. PGRN increased fEPSPs slope in the presence of TNFR1 antibody but not in the presence of TNFR2 antibody [F(2,21) = 12.86, P 5 0.001, Fig. 6E ]. Furthermore, TNFR2 antibody blocked phosphorylation of GluA1 (p-GluA1-ser845/831); this phosphorylation is induced by PGRN (100 ng/ml) or glycine (200 mM) in wild-type cultured neurons [p-GluA1-ser845, F(5,24) = 35.18, P 5 0.001; p-GluA1-ser831, F(5,24) = 36.79, P 5 0.001, Fig. 6F and G]. These results indicate that PGRN facilitated phosphorylation of p-GluA1 and L-LTP in TNFR2-dependent manner.
PGRN activates the TNFR2/NFkB pathway
Activation of nuclear factor kappa B (NFkB) contributes to synaptic plasticity (Albensi and Mattson, 2000; Ahn et al., 2008; Snow et al., 2014) . One of the NFkB subunits, RELB, was higher in mPFC of KO mice than that in wildtype mice according to immunofluorescence staining (P 5 0.001, unpaired Student's t-test, Fig. 7A ). Exogenous PGRN (100 ng/ml) activated NFkB subunits, including p50, p52, and RELB but not RELA in cultured wild-type neurons [p50, F(3,16) = 21.28, P 5 0.001; p52, F(3,16) = 26.49, P 5 0.001; RELA, F(3,16) = 1.10, P = 0.31; RELB, F(3,16) = 22.07, P 5 0.001; TNFa, F(3,16) = 0.78, P = 0.52; TNFR2, F(3,16) = 31.81, P 5 0.001, Fig. 7B ]. Because RELA elevation is specifically TNFR1 activity-dependent while RELB elevation is specifically TNFR2 activity-dependent, this result is consistent with a previous study that PGRN specifically activated TNFR2 (Rauert et al., 2010) . Activation of TNFR2 further induced the downstream c-Jun N-terminal kinase (JNK) phosphorylation [F(3,16) = 17.62, P 5 0.001, Fig. 7B ]. Furthermore, activations of NFkBs and JNK by PGRN were blocked by pretreatment of TNFR2 siRNA. Next, we compared levels of NFkB subunits in mPFC of wild-type and KO mice. Levels of cytoplastic and nuclear p52, RELA, and RELB were higher in mPFC of KO mice than in wild-type mice (Cytoplast: p52, P = 0.007; RELA, P 5 0.001; RELB, P 5 0.001, unpaired Student's t-test. Nucleus: p52, P = 0.009; RELA, P = 0.007; RELB, P = 0.007; unpaired Student's t-test, Fig. 7C and D) . The changes of two NFkB subunits p50 and RELA is not consistent between the culture neurons and tissues. This may be the compensatory effects in the KO mice as compared to the acute treatment of PGRN in cultured neurons. As RELB is a transcription factor regulating transcription of many genes by binding their promoters, we evaluated the RELB activity by quantifying the binding of RELB to DNA using ChIP.
As Fig. 7E indicated, the binding of RELB to DNA was higher in mPFC of KO mice than in wild-type mice (P 5 0.001, unpaired Student's t-test). Pro-caspase 8, a TNFR1 downstream effector, was not different between wild-type and KO mice (P = 0.37, unpaired Student's t-test, Fig. 7C ). These results indicate that PGRN can specifically activate the TNFR2/NFkB pathway and that TNFR2/NFkB signalling is enhanced in mPFC of KO mice.
Blockade of TNFR2/NFkB pathway ameliorates behaviour deficits in FMR1KO mice
Next, we tested whether downregulation of TNFR2/NFkB signalling could ameliorate abnormal behaviours in Fmr1 KO mice. Thalidomide (TNFa synthesis blocker), TAPI-0 (inhibitor of transmembrane TNFa conversion into soluble TNFa), and JSH-23 (inhibitor of NFkB nuclear translocation) were used to regulate TNFR2/NFkB signalling pathways (Koo et al., 2010; Lee et al., 2014) . Drugs were administered (i.p.) once a day for 1 week before testing trace fear memory. Blockade of TNFa synthesis or transformation with thalidomide or TAPI-0 did not improve performance of trace fear memory of Fmr1 KO mice in the testing phase. However, thalidomide improved learning ability in the training phase and decreased hyperactivity in KO mice [training phase ITI 10, F(5,42) = 31.62, P 5 0.001, Fig. 8A ; open field: F(5,42) = 34.69, P 5 0.001, Fig. 8B ]. As Fig. 8C indicated, thalidomide did not repress the activation of p52 or RELB in KO mice, but TAPI-0 treatment increased activities of p52 and RELB in both wild-type and KO mice [p52, F(5,30) = 41.57, P 5 0.001; RELB, F(5,30) = 40.93, P 5 0.001]. This may be that TAPI-0 increases the membrane TNFa, and membrane TNFa preferentially activates TNFR2 (Volosin et al., 2008) . NFkB activation is needed for fear memory formation (Oikawa et al., 2012; Jarome et al., 2015) . Consistent with this finding, treatment with JSH-23, which inhibited NFkB subunits nuclear translocation in KO mice Single injection of JSH-23 (2 mg/kg, i.p.) also improved learning and memory of KO mice ( Supplementary Fig. 5 ). These data suggest that NFkB activation, rather than TNFa synthesis, is critical for learning and memory, and that other cytokines or growth factors may compensate for low TNFa synthesis. This also indicates different functions of each NFkB subunit. To further confirm the function of PGRN/TNFR2/NFkB signalling, we double-knocked down PGRN and TNFR2 in mPFC using shRNAs. Single knock-down of PGRN or TNFR2 was sufficient to improve trace fear memory [training phase ITI 10, F(4,35) = 25.51, P 5 0.001; testing phase, F(4,35) = 26.46, P 5 0.001, Fig. 8G ] and motor activity in KO mice [F(4,35) = 24.91, P 5 0.001, Fig. 8H ]. However, further synergistic effects were not observed in KO mice with double knock-down of PGRN and TNFR2 suggesting that PGRN and TNFR2 may share the similar signalling pathway.
Discussion
In the present study, we found a higher level of PGRN in mPFC of Fmr1 KO mice compared to wild-type mice. Excessive PGRN contributed to abnormal dendritic spine development and impaired LTP by over-activating the TNFR2/NFkB signalling pathway. In Fmr1 KO mice, partial downregulation of PGRN restored spine development, synaptic plasticity, hyperactivity, and learning and memory. PGRN induced phosphorylation of GluA1 and nuclear translocation of NFkB, which is necessary for LTP expression. However, in KO mouse cortex, excessive PGRN maintained higher NFkB activity, which blocked the activity-dependent synaptic plasticity. JSH-23, an inhibitor of NFkB translocation blocker, improved learning and memory and decreased hyperactivity in Fmr1 KO mice. These results provide new insight into the function of PGRN/TNFR2/NFkB signalling in learning and memory, and imply the potential target for cognitive deficit of FXS.
Interestingly, the increase in PGRN expression is observed in mPFC but not in hippocampus, a brain region critical for learning and memory. This inconsistent expression of PGRN may be one of the molecular basis of the different patterns of synaptic plasticity in mPFC and hippocampus in Fmr1 mice. For example, LTD is exaggerated in hippocampus with the normal LTP (Godfraind et al., 1996; Huber et al., 2002) , whereas LTP is deficit in the PFC (Zhao et al., 2005) . However, the inconsistent levels of PGRN between PFC and hippocampus need further research.
FMRP is a repressor of mRNA translation. In Fmr1 KO mice, loss of FMRP leads to dysregulation of hundreds of genes (Ascano et al., 2012) . Mental retardation is a critical phenotype of FXS; this phenomenon is mirrored in Fmr1 KO mice because of excessive protein synthesis (Bhattacharya et al., 2012) . mGluR theory is a promising mechanism of cognitive disability in FXS (Bear et al., 2004) . Specific mGluR antagonists are regarded as potential treatments for FXS. However, adverse side effects limit their use in clinical research. mTOR and ERK signalling cascades are regulated by mGluRs (Gebauer and Hentze, 2004) and overactivated in Fmr1 KO mice (Bhakar et al., 2012) . In mPFC, microinjection of PGRN shRNA suppressed upregulation of phosphorylated AKT, mTOR, ERK, and b-catenin signalling in Fmr1 KO mice. Thus, inhibition of excessive PGRN antagonizes mGluR signalling cascade in FXS.
PGRN regulates neurite outgrowth and enhances neuronal survival (Van Damme et al., 2008) . Activity-dependent reduction in synaptic strength occurs in the developing brain and therefore suggests an essential step in synaptic pruning and postnatal development of neural circuits (Bian et al., 2015) . PGRN plays critical roles in synaptic transmission and plasticity as previously reported (Tapia et al., 2011; Lui et al., 2016) . However, in the present study we found that overexpression of PGRN is noxious for the synaptic functions by increasing the dendritic spine density and the percentage of immature spines. The right level of PGRN is critical for the spine development and basal synaptic transmission. Excessive PGRN possibly delayed maturation of spines and retained their naïve state. Learning and memory may be prevented by a high ratio of immature spines. Owing to low efficiency of synaptic transmission in neurons with immature spines, more neurotrophic factors are compensatory to release; these factors can further stunt spine development. During the first postnatal week of rats, dendritic filopodia emerged and interacted with axons to the form of nascent synapses. Thin spines and mushroom spines emerged during the second postnatal week (Harris, 1999) . We noted changes in PGRN levels throughout development. PGRN levels in mPFC increased gradually from the first postnatal week and peaked on second week. In Fmr1 KO mice, PGRN levels were higher compared to wild-type mice at all postnatal time points. This alteration of PGRN levels in KO mice implies the critical role of PGRN in spine maturation in early postnatal life.
Spine morphology can be classified into three types, i.e. thin, mushroom, and stubby. The thin spine type lacks a bulbous head and is found on dendrites of developing neurons. Morphological changes in spines are closely related to information input, which is involved in many fundamental processes, such as learning and memory (Gonzalez-Ramirez et al., 2014) . Morphological plasticity of spines is closely related to functional plasticity, i.e. synaptic plasticity. LTP is synaptic transmission potentiation and is thought to be (10 mg/kg) and TAPI-0 (1 mg/kg) were administered intraperitoneally for 1 week before testing trace fear memory. n = 8 mice in each group. Twoway ANOVA followed by Bonferroni's post hoc test; *P 5 0.05, **P 5 0.01 versus saline injected wild-type mice; ## P 5 0.01 versus saline injected KO mice. (B) Open field test to detect locomotor activity. Two-way ANOVA followed by Bonferroni's post hoc test; *P 5 0.05, **P 5 0.01 versus Elevated progranulin in fragile X syndrome BRAIN 2017: 140; 3215-3232 | 3229 the cellular basis of learning and memory (Bliss and Collingridge, 1993) . L-LTP is associated with enlargement and remodelling of postsynaptic densities, enlargement of pre-existing dendritic spines, and is transcription-and translation-dependent (Frey et al., 1993; Abel et al., 1997) . Partial knock-down of PGRN restored the proportion of mushroom spines in KO mice. Accordingly, functional recovery was observed in PGRN shRNA treated mice. Partial knock-down of PGRN restored L-LTP in Fmr1 KO slices and reversed trace fear memory deficits. Exogenous PGRN facilitated synaptic transmission and GluA1 phosphorylation in wild-type mice but not in KO mice. Possibly, in Fmr1 KO mice, high basal level of PGRN prevented further facilitation of synaptic plasticity by exogenous PGRN. This event is proven by the fact that in Fmr1 KO mice, synaptic plasticity and memory deficits were alleviated by partial knock-down of PGRN or downregulation of TNFR2/NFkB signalling. This finding confirms the hypothesis that excessive PGRN disrupts morphological and functional plasticity in Fmr1 KO mice.
There are significant controversies regarding the role of TNFR in PGRN action. For example, Tang et al. (2011) report that PGRN binds directly to TNFRs and prevents inflammation in multiple arthritis mouse models and inhibits TNFa-activated intracellular signalling (Tang et al., 2011) . Compared with TNFa, PGRN has significantly higher affinity for TNFR2 (Tang et al., 2011) . In another study, Hu et al. (2014) report that PGRN promotes, rather than inhibits, the functional consequence of TNF-TNFR2 interaction on regulatory T cells. In addition, Chen et al. (2013) suggested that PGRN did not bind TNFRs and is not a direct regulator of TNF-dependent signalling or bioactivity in immune or neuronal cells (Chen et al., 2013) . However, in the present study we indicate that PGRN binds directly to TNFRs, with a preference for TNFR2 in mPFC lysates. It is consistent with Tang et al. (2011) . Functions of TNFa depend on activated subtypes of TNFR. TNFR1 contributes to cell damage, whereas TNFR2 plays protective roles in neuronal survival (Balosso et al., 2005) . TNFR1 can bind to either soluble TNFa or transmembrane TNFa but with preference for soluble TNFa. By contrast, transmembrane TNFa preferentially activates TNFR2. Thus, we would like to define PGRN as a competitive binding ligand rather than an antagonist of TNFa. In the present study, PGRN is considered as an activator of TNFR2. PGRN facilitated synaptic transmission through the TNFR2/NFkB pathway, as shown by abolishment of PGRN-mediated synaptic facilitation by TNFR2 blocking antibody. These results broaden our understanding regarding the role of PGRN and TNFa in synaptic facilitation and L-LTP expression.
Pharmacological agents can differentiate TNFR2/NFkB signalling pathway at different levels. In Fmr1 KO mice, trace fear memory was not improved by inhibition of TNFa synthesis or conversion of transmembrane TNFa into soluble TNFa. However, inhibition of NFkB nuclear translocation improved trace fear memory in Fmr1 KO mice, indicating that NFkB activation, rather than TNFa synthesis, is critical for improved performance of learning and memory. The possibility is that inhibition of TNFa synthesis is compensated by other cytokines or growth factors.
To further confirm the functional role of TNFR2/NFkB signalling in PGRN-mediated learning and memory, we performed double knock-down of PGRN and TNFR2 in mPFC. Single knock-down of either PGRN or TNFR2 improved memory performance. However, double knockdown of PGRN and TNFR2 did not show synergistic effects, suggesting that PGRN and TNFR2 share a similar signalling pathway.
In summary, we found higher levels of PGRN in mPFC of Fmr1 KO mice compared to wild-type mice. Excessive PGRN contributed to abnormal dendritic spine development and impaired LTP by overactivating the TNFR2/ NFkB signalling pathway (Fig. 8I) . This work provides evidence that excessive PGRN induces abnormal spine development during critical period of synaptogenesis and contributes to cognitive impairments associated with FXS. ## P 5 0.01 versus saline injected KO mice. (C) Western blot samples showed nuclear NFkB subunits translocation in mPFC after thalidomide or TAPI-0 treatment. n = 6 mice in each group. Two-way ANOVA followed by Bonferroni's post hoc test; *P 5 0.05, **P 5 0.01 between the groups as shown. (D) Western blot samples showed nuclear NFkB subunits translocation in mPFC after JSH-23 treatment. n = 6 mice in each group. Two-way ANOVA followed by Bonferroni's post hoc test; *P 5 0.05, **P 5 0.01 between the groups as shown. (E and F) Effects of JSH-23 (2 mg/kg) on fear conditioning and locomotor activity. n = 8 mice in each group. Two-way ANOVA followed by Bonferroni's post hoc test; *P 5 0.05, **P 5 0.01 versus saline injected wild-type mice; ## P 5 0.01 versus saline injected KO mice. (G and H)
Effects of knock-down PGRN and TNFR2 in mPFC by shRNAs on trace fear memory and locomotor activity. n = 8 mice in each group. Two-way ANOVA followed by Bonferroni's post hoc test; **P 5 0.01 versus scrambled shRNA injected wild-type mice; ## P 5 0.01 versus scrambled shRNA injected KO mice. (I) Schematic of PGRN/TNFR mediated signalling. Left: Normally, PGRN binds to TNFR2 and activates downstream effector molecules. It leads to activation and nuclear translation of NFkB, which are critical for the spine development and synaptic plasticity. Right: Excessive PGRN induces overactivating TNFR2/NFkB signalling pathway, leading to abnormal spine development and impaired synaptic plasticity in mPFC of Fmr1 KO mice. WT = wild-type.
